Irrelevance of microsatellite instability in the epidemiology of sporadic pancreatic ductal adenocarcinoma
about
Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinomaKRAS mutation in lung metastases from colorectal cancer: prognostic implications.MIA PaCa-2 and PANC-1 - pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors.Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision MedicineCCR7 regulates Twist to induce the epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.Clinical study of genomic drivers in pancreatic ductal adenocarcinoma.Pancreatic Cancer in Lynch Syndrome Patients.Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704.Hypermutation and microsatellite instability in gastrointestinal cancers.Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4.Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations.Reviewing the Utility of EUS FNA to Advance Precision Medicine in Pancreatic Cancer.A Contemporary Review of the Treatment Landscape and the Role of Predictive and Prognostic Biomarkers in Pancreatic Adenocarcinoma.Upper gastrointestinal malignancies in 2017: current perspectives and future approaches.Mismatch repair status may predict response to adjuvant chemotherapy in resectable pancreatic ductal adenocarcinoma.Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approachesCurrent approaches to immunotherapy in noncolorectal gastrointestinal malignancies
P2860
Q28069864-1EADF34B-904B-4E50-A479-0A9ED9DFBA15Q36528345-9CC0678E-C02F-47A2-BC6C-BE5107B0A5B1Q36588574-60871550-4DB6-4FE1-ABC8-0533AF9B2B13Q37230991-0F443047-CF1C-42A3-B4D0-CCCD2017AD38Q38848480-25495854-EF34-482E-8189-2F74CCA8E621Q45063614-BD80D4D2-1AA5-4074-8636-C10991CFC2B8Q47153954-11798506-D0DE-4D88-8420-6BB209B64B97Q47624692-E6D1BEDB-2CD4-4E1D-98E8-6F3B97460660Q47655313-041D1B63-68C4-4D98-AF2D-5C20EB9BCEF0Q47657981-A858EBAE-E351-4612-9846-1FCB1043F5FCQ47713578-182A7F2F-BEFB-4C21-AD36-26D247165BE2Q49576059-5C33DD96-7FFE-4FCC-A22C-53E6B66713CDQ52603515-9DB4E108-A303-45B0-945D-D4578C05A806Q52654643-259ADD4D-D005-4AFF-873C-D23D02E4427FQ52927231-A09EF8D3-B190-4445-BA94-A85548DBBA92Q55240544-DCFCB952-7B5E-4406-8AD4-3994FA8F8AD0Q56889396-8750488C-C7C2-4A27-B7B5-275CFD37BF95Q58594584-85BD42A3-B9BF-473E-A2F4-0725574CE2AB
P2860
Irrelevance of microsatellite instability in the epidemiology of sporadic pancreatic ductal adenocarcinoma
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Irrelevance of microsatellite ...... ncreatic ductal adenocarcinoma
@ast
Irrelevance of microsatellite ...... ncreatic ductal adenocarcinoma
@en
Irrelevance of microsatellite ...... ncreatic ductal adenocarcinoma
@nl
type
label
Irrelevance of microsatellite ...... ncreatic ductal adenocarcinoma
@ast
Irrelevance of microsatellite ...... ncreatic ductal adenocarcinoma
@en
Irrelevance of microsatellite ...... ncreatic ductal adenocarcinoma
@nl
prefLabel
Irrelevance of microsatellite ...... ncreatic ductal adenocarcinoma
@ast
Irrelevance of microsatellite ...... ncreatic ductal adenocarcinoma
@en
Irrelevance of microsatellite ...... ncreatic ductal adenocarcinoma
@nl
P2093
P2860
P50
P921
P1433
P1476
Irrelevance of microsatellite ...... ncreatic ductal adenocarcinoma
@en
P2093
Alberto Malesci
Alessandro Zerbi
Anna Brecht
Claudio Bassi
Gianluca Basso
Giona Turri
Giuseppe Celesti
Giuseppe Di Caro
Guido Schumacher
Ilona Gräntzdörffer
P2860
P304
P356
10.1371/JOURNAL.PONE.0046002
P407
P50
P577
2012-09-21T00:00:00Z